Terns Pharmaceuticals Inc (NAS:TERN)
$ 6.62 0.74 (12.59%) Market Cap: 428.17 Mil Enterprise Value: 145.90 Mil PE Ratio: 0 PB Ratio: 1.81 GF Score: 34/100

Terns Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 11, 2022 / 06:15PM GMT
Release Date Price: $2.57 (-1.53%)
Joey Stringer
Needham & Company, LLC - Analyst

Good afternoon, everyone. Thanks for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer; I'm one of the biotech analysts at Needham and Company. It's my pleasure to introduce our next presenting company, Terns Pharma. Joining us today from Terns is SVP, Chief Development Officer, Diana Chung. (Conference Instructions)

With that, we'll get started. I'll turn it over to Diana for the presentation.

Diana Chung
Terns Pharmaceuticals, Inc. - SVP, Chief Development Officer

Great. Thanks, Joey. Appreciate the introduction. Hello. My name is Diana Chung. I'm Chief Development Officer at Terns. I first wanted to thank the organizers of the Needham Healthcare Conference for allowing me the opportunity to present an update on Terns as well as our development program. For those in the audience, I would like to direct you to the Terns website to review our disclosure statements.

So Terns is a small biotech company based in the San Francisco Bay area, and we're focused on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot